跳至主要内容
临床试验/ISRCTN13287757
ISRCTN13287757已完成未知

The use of a screening tool in primary care to identify menopausal and perimenopausal women who could benefit from hormone replacement therapy

Rotherham, Doncaster, and South Humber NHS Foundation Trust (RDaSH)0 个研究点目标入组 63 人开始时间: 2021年8月13日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
63

研究概览

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • All women between the ages of 47 and 53 years who are currently not prescribed any form of hormone replacement therapy and who have no recorded contra-indications to using the treatment

排除标准

  • 1. Current, past or suspected breast cancer
  • 2. Known or suspected oestrogen-sensitive cancer
  • 3. Undiagnosed vaginal bleeding
  • 4. Untreated endometrial hyperplasia
  • 5. Previous idiopathic or current deep vein thrombosis or pulmonary embolism unless on anticoagulant therapy.
  • 6. Active or recent arterial thromboembolic disease (e.g. angina, myocardial infarction)
  • 7. Untreated hypertension
  • 8. Active liver disease with abnormal liver function tests
  • 9. Porphyria cutanea tarda
  • 10. Pregnancy

研究者

发起方
Rotherham, Doncaster, and South Humber NHS Foundation Trust (RDaSH)

相似试验